Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced it will report third quarter 2014 financial results on Thursday, November 13, 2014. Eleven’s management team will host a conference call and audio webcast at 8:30 a.m. EST, on Thursday, November 13, 2014 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
